Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26830
Abstract: Tranexamic acid (TXA) has been shown to decrease perioperative blood loss, transfusions, and cost in patients undergoing resection of aggressive bone tumors and endoprosthetic reconstruction. This study explored the effect of TXA administration on postoperative… read more here.
Keywords: endoprosthetic reconstruction; postoperative mobilization; patients undergoing; tranexamic acid ... See more keywords